Effect of heat stress on serotonin-2A receptor-mediated intracellular calcium mobilization in rat C6 glioma cells. 2000

A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
Department of Psychiatry and Neurosciences, Hiroshima University School of Medicine, Japan. kagaya@ue.ipc.hiroshima-u.ac.jp

This study was conducted to investigate an effect of heat stress at 44 degrees C for 30 min on intracellular Ca2+ signaling system and on heat shock protein (HSP)-70 expression. 5-HT-induced Ca2+ mobilization was reduced 1, 3 and 6 hrs after heat stress, and recovered to the control level 12 and 24 hrs after heat stress. One hr after heat stress, Ca2+ rise was significantly decreased when the cells were stimulated by any concentration of 5-HT. Thrombin-induced Ca2+ increase was also markedly reduced 1 hr after heat stress. HSP-70 level was increased 6 and 9 hr after heat stress. In HSP synthesis inhibitor quercetin-treated cells, HSP-70 expression was not enhanced after heat stress, and Ca2+ rise in response to 5-HT did not return to the control level. However, the Ca2+ rise induced by 5-HT was not restored to the control level after stress in Ac-Asp-Glu-Val-Asp-H (DEVD)-exposed cells while DEVD had little effect on heat stress-induced synthesis of HSP-70. Dexamethasone did not alter the change in HSP-70 expression or Ca2+ response after heat stress. These results indicate that heat stress attenuated 5-HT-induced Ca2+ mobilization and that HSP-70 expression played an important role in recovery from Ca2+ impairment, possibly via protease activity in C6 cells.

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011794 Quercetin A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. 3,3',4',5,7-Pentahydroxyflavone,Dikvertin
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
January 1996, Progress in neuro-psychopharmacology & biological psychiatry,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
January 1993, Neuroendocrinology,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
September 2004, Journal of neurochemistry,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
February 1998, Journal of neuroscience research,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
June 1994, Journal of neurochemistry,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
March 1994, Brain research,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
February 1999, Neuropeptides,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
June 2002, Acta pharmacologica Sinica,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
January 1992, Glia,
A Kagaya, and A Okada, and H Jitsuiki, and Y Tawara, and M Inagaki, and M Takebayashi, and T Saeki, and A Nishida, and Y Nakata, and S Yamawaki
February 2001, Physiological genomics,
Copied contents to your clipboard!